CTFP Volume 12 Issue 1

A publication of the American Thyroid Association

Table of Contents


Happy New Year and welcome to another year and another issue of Clinical Thyroidology for the Public. In this journal, we will bring to you the most up-to-date, cutting edge thyroid research. We also provide even faster updates of late-breaking thyroid news through Twitter at @thyroidfriends and on Facebook. Our goal is to provide patients with the tools to be the most informed thyroid patient in the waiting room. Also check out our friends in the Alliance for Thyroid Patient Education. The Alliance member groups consist of: the American Thyroid Association, Bite Me Cancer, the Graves’ Disease and Thyroid Foundation, the Light of Life Foundation, ThyCa: Thyroid Cancer Survivors’ Association, Thyroid Cancer Canada, Thyroid Cancer Alliance and Thyroid Federation International.

The American Thyroid Association (ATA) extends its appreciation to all of the patients and their families that are part of the ATA community — our Friends of the ATA. It is for you that the ATA is dedicated to carrying out our mission of providing reliable thyroid information and resources, clinical practice guidelines for thyroid detection and treatments, resources for connecting you with other patients affected by thyroid conditions, and cutting edge thyroid research as we search for better diagnoses and treatment outcomes for thyroid disease and thyroid cancer.

As we think of all those who make a difference in our lives this holiday season, we thank you for being part of the ATA family and for all of the Friends of the ATA who support our mission and work throughout the year to support us. We invite you to help keep the ATA mission strong by choosing to make a donation that suits you – it takes just one moment to give online at: www.thyroid.org/donate and all donations are put to good work. The ATA is a 501(c)3 nonprofit organization and your gift is tax deductible.

The editorial board of CTFP, the ATA Board of Directors, Members, and ATA Headquarters Staff, wish you the best this season and look forward to being part of your thyroid network in 2019.

January is Thyroid Awareness Month

In this issue, the studies ask the following questions:

  • Is the increased use of ultrasound the cause of the increase in diagnosis of thyroid cancer?
  • Does combining cancer staging systems with patient age improve survival predictions for thyroid cancer?
  • How effective is levatinib in treating patients with advanced thyroid cancer?
  • Does developing hypothyroidism while taking tyrosine kinase inhibitor drugs for non-thyroidal cancer increase survival?
  • Who orders rT3 testing in the United States?
  • Is combination therapy effective for severe Graves’ eye disease?

We welcome your feedback and suggestions. Let us know what you want to see in this publication. I hope you find these summaries interesting and informative.

Alan P. Farwell, MD, FACE